Varicose Veins Treatment Market To Surpass US$ 991.5 Million By 2027 - Coherent Market Insights

Posted October 9, 2020 by SANJAYCMI


Varicose veins may cause due to factors such as obesity, pregnancy, and old age. In majority of cases, patients do not suffer from blood circulation or long-term health problems. They might have an unpleasant appearance. However, most varicose veins do not require any treatment. If treatment is mandatory, physicians first recommend the use of compression stockings for six months and if the pain still persists or any complications are observed, varicose veins can be treated through ligation and stripping, sclerotherapy or endothermal ablation.


The global Varicose Veins Treatment Market is estimated to account for US$ 991.5 Mn in terms of value by the end of 2027

Global Varicose Veins Treatment Market: Drivers

Increasing prevalence of obesity is expected to aid in growth of the global varicose veins treatment market over the forecast period. For instance, according to, over 1.9 billion adults were reported as overweight worldwide.

Global Varicose Veins Treatment Market: Opportunities

Expansion of major hospitals in new and untapped regions is expected to offer lucrative growth opportunities for players in the market. For instance, in August 2019, Kim Byoung Joon Ledas Varicose Vein Clinic, a South Korea-based hospital that specializes in varicose veins, announced to enter the Mongolian market by signing a memorandum of understanding (MOU) to offer international medical care and build cooperative relations with two Mongolian medical institutions, one education agency, and one medical tourism company in Mongolia.

Browse Research Report:

Global Varicose Veins Treatment Market: Restraints

Use of alternative treatment options such as herbal remedies in emerging economies of Asia Pacific is expected to limit growth of the market over the forecast period. For instance, Ayurveda suggests the use of caster roots (pain reliever), Rubia cordifolia, Boehirravia diffusa (blood purifier), and Tinospora cardifolia (anti-infective) to naturally get rid of varicose vein.

Key Takeaways:

The Endovenous Laser Systems segment in the global varicose veins treatment market was valued at US$ 302.9 Mn in 2019 and is expected to reach US$ 546.7 Mn by 2027 at a CAGR of 7.7% during the forecast period. Increasing prevalence of obesity is expected to aid in growth of the segment over the forecast period

The Ambulatory Surgical Centers segment held dominant position in the global varicose veins treatment market in 2019, accounting for 36.9% share in terms of value, followed by hospital segment, respectively. The growth of the segment is attributed to increasing demand for same day procedures in developed economies of the world.

Market Trends

Major institutes and universities are focused on R&D activities related to varicose vein treatment devices. For instance, in August 2019, the Department of General Surgery of Tirunelveli Medical College Hospital, India started performing Radio Frequency Ablation (RFA) procedure for varicose veins.

Increasing funding and investment in R&D related to varicose vein treatment is also expected to boost the market growth. For instance, in August 2019, Palatine Private Equity LLP announced that it has made a ‘significant investment’ into Veincentre – a UK-based center focused on the treatment of all varicose veins and thread veins and provider of endovenous laser ablation (EVLA) for the management of varicose veins.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report:

Global Varicose Veins Treatment Market: Competitive Landscape

Major players operating in the global varicose veins treatment market include, 1. AngioDynamics, Inc., Syneron Medical Ltd., Dornier Medtech GmbH., Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, WONTECH Co., Ltd., Intros Medical Laser GmbH, Energist Ltd.

Global Varicose Veins Treatment Market: Key Developments

July 2019: Harvest One Cannabis Inc. acquired Delivra Corp., a specialty biotechnology company that manufactures and sells transdermal delivery system platform for nerve pain, varicose veins, and other conditions

April 2019: Medtronic plc announced five-year outcomes from the VeClose Extension Study, which demonstrated durable and consistent long-term outcomes of the Medtronic VenaSeal Closure System for the treatment of chronic venous disease

January 2019: Venclose Inc. partnered with Viant, an ISO-certified medical device contract manufacturer, for developing next-generation vein treatment solutions that include Venclose's VENCLOSE TM RF Ablation Catheter

Buy-Now this research report:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags Varicose Vein Treatment Market Research , Varicose Vein Treatment Market , Varicose Vein Treatment Market Outlook
Last Updated October 9, 2020